[Effect of FK506 and CSA on the cell survival of engrafted HSC and the level of IL-2 and IL-4 in leukemia mice].
To explore the effect of FK506 and CSA on the survival of HSCs and the level of IL-2 and IL-4. The WEHI23 cells were injected into vein from tail of mice to set up the leukemia model. The Hematopoietic stem cells (HSCs) were harvested from GFP mice and cultured in vitro, then injected into the vein of leukemia mice. FK506 and CSA, as two immunosuppress agents, were applied in leukemia mice and intact mice, and leukemia mice were as control. Some HSCs could survive in the host treated with FK506 and CSA at least 2 weeks, while HSCs survived only 1 week in intact or leukemia control mice. Simultaneously, the level of IL-2 and IL-4 in leukemia mice treated with FK506 and CSA decreased significantly than those of intact or leukemia control mice. FK506 can promote the survival of HSCs in host, and the mechanism may be associated with the down regulation of IL-2 and IL-4.